Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Britain's medical regulator says urgently reviewing AstraZeneca COVID-19 vaccine trial data
(Reuters) - Britain’s medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca can restart trials of its experimental coronavirus v...
U.N.'s Guterres calls for $35 billion more for WHO COVID-19 program
ZURICH (Reuters) - United Nations Secretary General Antonio Guterres called for $35 billion more, including $15 billion in the next three months, for the World Health Organization’s (WHO...
NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with C...
HHS Authorizes Pharmacists to Order, Administer COVID-19 Vaccine
In an effort to expand access to the coronavirus disease 2019 (COVID-19), the Department of Health and Human Services (HHS) has authorized state-licensed pharmacists to order and admin...
FDA approves Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US
New asthma indication for Trelegy Ellipta introduces an important option for patients to the current treatment paradigmGlaxoSmithKline plc (LSE/NYSE.
Brazil trials of Sinovac COVID-19 vaccine show promising results: governor
SAO PAULO (Reuters) - The governor of Brazil’s São Paulo state said on Wednesday that Phase 3 clinical trials of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd have...
China-developed nasal spray vaccine for COVID-19 approved for clinical trials
HONG KONG — The University of Hong Kong (HKU) Wednesday announced that the clinical trials of a nasal spray vaccine for COVID-19 jointly developed by the university's Department of Micro...
France fines Roche, Novartis 444 million euros in ongoing eye drug clash
ZURICH (Reuters) - Switzerland’s Novartis and Roche were fined 444 million euros (403.
Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD
Osaka, JAPAN, September 8, 2020 – Takeda Pharmaceutical Company Limited (TSE.
CanSino Phase 3 COVID-19 vaccine trial in Pakistan expected to begin this month
ISLAMABAD (Reuters) - Falling COVID-19 infection numbers in Pakistan will not affect a Phase 3 clinical trial for a potential vaccine being developed by China’s CanSino Biologics, which is e...
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
Alarge, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.
Mylan Acquires Aspen's European Thrombosis Portfolio for $757.3 Million
Netherlands-based Mylan is buying the intellectual property and commercialization rights to Aspen Pharmacare’s thrombosis business in Europe for €641.
23
24
25
26
27
28
29
30
31
